IGM Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
IGM Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • IGM Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $33M, a 14% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $33M -$5.37M -14% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $34.5M -$4.62M -11.8% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $35.8M -$3.82M -9.64% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $37.1M +$10.1M +37.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $38.4M +$10.3M +36.8% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $39.1M +$10.2M +35.1% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $39.6M +$11.7M +42.2% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $27M -$1.6M -5.61% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $28.1M +$16.2M +135% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $28.9M +$16.2M +127% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $27.8M +$16.3M +140% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $28.6M +$16.3M +134% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $11.9M -$949K -7.37% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $12.8M -$750K -5.55% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $11.6M -$2.55M -18% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $12.2M +$2.35M +23.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $12.9M Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $13.5M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $14.1M +$13.5M +2256% Dec 31, 2019 10-K 2021-03-30
Q3 2019 $9.88M Sep 30, 2019 10-Q 2019-11-07
Q4 2018 $600K Jan 1, 2019 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.